摘要
目的:了解川北医学院附属医院(以下简称"我院")肿瘤科住院患者使用麻醉药品的情况。方法:采用回顾性调查方法,调取2013—2015年我院肿瘤科住院患者使用麻醉药品的数据,对药品用量、销售金额、用药频度、排序比(药品销售金额排序/用药频度排序)等进行统计分析。结果:2013—2015年我院住院癌性疼痛患者使用的麻醉药品中,吗啡缓释片最常用,且其用量与销售金额逐年增加;盐酸吗啡缓释片的用药频度和销售金额最高,分别为12 550.4和214 952.8元,其限定日费用为17.1元;除芬太尼透皮贴与盐酸吗啡注射液外,其余药品的排序比均>1.0。结论:我院肿瘤科住院患者麻醉药品的使用基本合理,以吗啡缓释片为主,符合《癌症疼痛诊疗规范(2011年版)》的要求。
OBJECTIVE： To investigate the application status of narcotic drugs for inpatients with cancer pain in Affiliated Hospital of North Sichuan Medical College（ hereinafter referred to as ＂our hospital ＂）. METHODS： By retrospective investigation method,the application data of narcotic drugs for inpatients with cancer pain in our hospital during 2013-2015 were extracted. Statistical analysis was conducted on the consumption amount,consumption sum,defined daily dose system（ DDDs） and ranking ratio（ consumption sum ranking / DDDs ranking）. RESULTS： Of all the narcotic drugs for inpatients with cancer pain in our hospital during 2013-2015,Morphine sustained-release tablets took the lead of usage frequency,and the usage and consumption sum were in a increasing tread. The DDDs and consumption sum of Morphine hydrochloride sustained release tablets took the lead,respectively 12 550. 4 yuan and214 952. 8 yuan,the DDC was 17. 1 yuan. Except for fentanyl transdermal system and Morphine hydrochloride injections,the ranking ratio of other drugs were 〉1. 0. CONCLUSIONS： The application of narcotic drugs for inpatients with cancer pain was basically rational,Morphine sustained-release tablets is the predominant drugs which is in line with the requirements of Standard of Diagnosis and Treatment of Cancer Pain（ 2011）.
出处
《中国医院用药评价与分析》
2016年第11期1533-1535,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
麻醉药品
恶性肿瘤
疼痛
用药分析
Narcotic drugs
Cancer
Pain
Analysis of drug application
